期刊文献+

幽门螺杆菌感染合并消化性溃疡的治疗分析 被引量:7

Diagnostic Analysis of Helicobacter Pylori Complicated with Peptic Ulcer Infection
下载PDF
导出
摘要 目的探究幽门螺杆菌(Hp)感染合并消化性溃疡患者的有效治疗方法,为临床治疗提供依据。方法选择2009年1月—2012年11月本院门诊或病房收治的Hp感染合并消化性溃疡的患者86例,随机分成A、B组两组,各43例。A组给予奥美拉挫+阿莫西林+克拉霉素治疗,B组患者在A组治疗的基础上服用乳酸菌素片。比较两组患者临床效果及不良反应发生情况。结果 B组Hp根治有效率及临床治疗有效率均高于A组,不良反应发生率低于A组,差异有统计学意义(P<0.05)。结论益生菌联合三联疗法治疗消化性溃疡合并幽门螺杆菌感染疗效显著,不良反应少,值得临床推广应用。 Objective To explore the effective treatment for patients with Helicobacter pylori combined with peptic ul-cer infection and provide basis for clinical treatment. Methods 86 cases of Helicobacter pylori combined with peptic ulcer in-fection in this hospital from January 2OO9 to November 2O12,were randomly divided into group A and B,43 cases of each group. Group A was treated with omeprazole,amoxicillin and clarithromycin;Group B was treated with Lacidophilin tablets on the basis of group A. Clinical effect and adverse reactions occur of two groups were compared. Results Helicobacter pylori erad-ication rate and clinical treatment efficiency of group B were higher than those of group A,and the incidence of adverse reactions of group B was lower than that of group A,the difference were statistically significant(P 〈 O. O5). Conclusion Probiotics combined with triple therapy treating Helicobacter pylori combined with peptic ulcer infection can improve the curative effect, and reduce the occurrence of adverse reactions,worthy of clinical popularization and application.
作者 宋远昌
出处 《临床合理用药杂志》 2014年第12期73-74,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 消化性溃疡 螺杆菌 幽门 益生菌 治疗结果 Peptic ulcer Helicobacter pylori Probiotics Treatment outcome
  • 相关文献

参考文献6

二级参考文献29

  • 1Rossella Cianci,Massimo Montalto,Franco Pandolfi,Giovan Battista Gasbarrini,Giovanni Cammarota.Third-line rescue therapy for Helicobacter pylori infection[J].World Journal of Gastroenterology,2006,12(15):2313-2319. 被引量:31
  • 2郑青,潘嬿,张林,萧树东.评估以雷贝拉唑为基础的三联和四联方案根除幽门螺杆菌的疗效[J].胃肠病学,2006,11(11):645-647. 被引量:14
  • 3徐顺福,施瑞华,张国新,丁岩冰,孙桂前,张红杰,陈晓星,黄霞玥,李学良,严志刚,苗毅.江苏地区幽门螺杆菌感染及其危险因素调查[J].世界华人消化杂志,2006,14(35):3363-3370. 被引量:26
  • 4Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther, 2002, 16 Suppl 1: 3-15.
  • 5Valeur N, Engel P, Carbajal N, et al. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol, 2004, 70 (2): 1176-1181.
  • 6Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion, 2001, 63 (1): 1-7.
  • 7Sykora J, Valeckov;i K, Amlerov;i J, et al. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study. J Clin Gastroenterol, 2005, 39 (8): 692-698.
  • 8Sheu BS, Wu JJ, Lo CY, et al. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2002, 16 (9): 1669-1675.
  • 9Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther, 2000, 14 (12): 1625- 1629.
  • 10Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther, 2001, 15 (2):163-169.

共引文献52

同被引文献57

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部